Skip to main content

Advertisement

SpringerLink
Log in

CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) patients with peritoneal carcinomatosis (PC) have a poor prognosis. Over the last decade, increasing evidence has suggested that the Collagen Triple Helix Repeat Containing 1 (CTHRC1) gene is involved in cancer progression and invasion. In this study, we investigated the expression of CTHRC1 in CRC and its potential as a prognostic factor for CRC patients with PC. Microarray analysis of four fresh paired samples showed that the expression of CTHRC1 in peritoneal metastases was higher than that in the corresponding primary tumor. These results were validated using semi-quantitative reverse transcription and polymerase chain reaction. Finally, immunohistochemical analysis showed that CTHRC1 was increased in the peritoneal metastasis group (n = 30) and the primary cancer with peritoneal metastasis group (n = 57) compared to the primary cancer without peritoneal metastasis group (n = 54), both P < 0.001. Cox proportional hazards model analysis showed that high CTHRC1 expression was associated with poor survival (HR = 2.754, P < 0.001, 95 % CI 1.731–4.383). Overall, the results of our study suggest that increased expression of CTHRC1 is associated with PC in CRC patients and could predict poor outcome in CRC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243(2):212–22. doi:10.1097/01.sla.0000197702.46394.16.

    Article  PubMed  Google Scholar 

  2. Gomez-Portilla A, Cendoya I, Lopez de Tejada I, Olabarria I, Magrach L, Martinez de Lecea C, et al. Principles of the treatment of peritoneal carcinomatosis due to colorectal cancer. Current review and update. Cir Esp. 2005;77(1):6–17.

    Article  PubMed  Google Scholar 

  3. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer J Int du Cancer. 2007;121(9):2005–12. doi:10.1002/ijc.22975.

    Article  CAS  Google Scholar 

  4. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24(2):305–12.

    PubMed  Google Scholar 

  5. Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res. 2005;96(2):261–8. doi:10.1161/01.RES.0000154262.07264.12.

    Article  PubMed  CAS  Google Scholar 

  6. Ip W, Wellman-Labadie O, Tang L, Su M, Yu R, Dutz J, et al. Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survival. J Cutan Med Surg. 2011;15(2):103–10.

    PubMed  CAS  Google Scholar 

  7. Tang L, Dai DL, Su M, Martinka M, Li G, Zhou Y. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res Off J Am Assoc Cancer Res. 2006;12(12):3716–22. doi:10.1158/1078-0432.CCR-06-0030.

    Article  CAS  Google Scholar 

  8. Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA. 2011;306(4):410–9. doi:10.1001/jama.2011.1029.

    Article  PubMed  CAS  Google Scholar 

  9. Wang P, Wang YC, Chen XY, Shen ZY, Cao H, Zhang YJ, et al. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-beta1 and may be associated with metastasis in human gastric cancer. Cancer Sci. 2012;. doi:10.1111/j.1349-7006.2012.02292.x.

    Google Scholar 

  10. Varghese S, Burness M, Xu H, Beresnev T, Pingpank J, Alexander HR. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol. 2007;14(12):3460–71. doi:10.1245/s10434-007-9557-7.

    Article  PubMed  Google Scholar 

  11. Lin BR, Chang CC, Chen RJ, Jeng YM, Liang JT, Lee PH, et al. Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17(10):3077–88. doi:10.1158/1078-0432.ccr-09-3256.

    Article  CAS  Google Scholar 

  12. Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jons T, Kemmner W. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int J Cancer J Int Cancer. 2008;123(2):409–13. doi:10.1002/ijc.23466.

    Article  CAS  Google Scholar 

  13. Gillern SM, Chua TC, Stojadinovic A, Esquivel J. KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome. Am J Clin Oncol. 2010;33(5):456–60. doi:10.1097/COC.0b013e3181b4b160.

    Article  PubMed  Google Scholar 

  14. Kharaishvili G, Cizkova M, Bouchalova K, Mgebrishvili G, Kolar Z, Bouchal J. Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study. J Clin Pathol. 2011;64(11):977–82. doi:10.1136/jclinpath-2011-200106.

    Article  PubMed  Google Scholar 

  15. Wang L, Xiang YN, Zhang YH, Tu YT, Chen HX. Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma. Br J Dermatol. 2011;164(1):135–40. doi:10.1111/j.1365-2133.2010.10050.x.

    Article  PubMed  CAS  Google Scholar 

  16. Ceelen WP, Bracke ME. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment. Lancet Oncol. 2009;10(1):72–9. doi:10.1016/S1470-2045(08)70335-8.

    Article  PubMed  Google Scholar 

  17. Ghosh AK. Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood). 2002;227(5):301–14.

    CAS  Google Scholar 

  18. LeClair RJ, Durmus T, Wang Q, Pyagay P, Terzic A, Lindner V. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res. 2007;100(6):826–33. doi:10.1161/01.res.0000260806.99307.72.

    Article  PubMed  CAS  Google Scholar 

  19. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 1996;86(4):543–52.

    Article  PubMed  CAS  Google Scholar 

  20. Arai T, Akiyama Y, Okabe S, Ando M, Endo M, Yuasa Y. Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett. 1998;122(1–2):157–63.

    Article  PubMed  CAS  Google Scholar 

  21. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810. doi:10.1146/annurev.cellbio.20.010403.113126.

    Article  PubMed  CAS  Google Scholar 

  22. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 2005;14(6):1583–8.

    PubMed  CAS  Google Scholar 

  23. Katoh M. Integrative genomic analyses of WNT11: transcriptional mechanisms based on canonical WNT signals and GATA transcription factors signaling. Int J Mol Med. 2009;24(2):247–51.

    Article  PubMed  CAS  Google Scholar 

  24. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006;4(4):e115. doi:10.1371/journal.pbio.0040115.

    Article  PubMed  Google Scholar 

  25. Yamamoto S, Nishimura O, Misaki K, Nishita M, Minami Y, Yonemura S, et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell. 2008;15(1):23–36. doi:10.1016/j.devcel.2008.05.007.

    Article  PubMed  CAS  Google Scholar 

  26. Palma M, Lopez L, Garcia M, de Roja N, Ruiz T, Garcia J, et al. Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer. BMC Clin Pathol. 2012;12:2. doi:10.1186/1472-6890-12-2.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Professor Yongjian Deng for his support in collecting the paraffin-embedded tissue samples and Dr. Xinhua Zhou for her critical review of the images of the immunostained slides.

Conflict of interest

The authors have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of General Surgery, Nanfang Hospital, Southern Medical University, No. 1838 Guangzhou Avenue North, Guangzhou, 510515, China

    Fei Tan, Feng Liu, Hao Liu, Yanfeng Hu, Dongning Liu & Guoxin Li

Authors
  1. Fei Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanfeng Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dongning Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guoxin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guoxin Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, F., Liu, F., Liu, H. et al. CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis. Med Oncol 30, 473 (2013). https://doi.org/10.1007/s12032-013-0473-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0473-3

Keywords

Search

Navigation